Efficacy News and Research

RSS
New drug targets main culprit in common colds

New drug targets main culprit in common colds

Oxygen Biotherapeutics develops gel version of Oxycyte for treating surface wounds

Oxygen Biotherapeutics develops gel version of Oxycyte for treating surface wounds

Luminaries call for continued support for an AIDS vaccine to end the epidemic

Luminaries call for continued support for an AIDS vaccine to end the epidemic

FDA warns consumers about Baltimore Medicine Shoppe pharmacies

FDA warns consumers about Baltimore Medicine Shoppe pharmacies

Medicinal cannabis effective for neuropathic pain in HIV

Medicinal cannabis effective for neuropathic pain in HIV

USPTO issues patent for methodologies for abating a broad range of allergens, pathogens, viruses, bacteria

USPTO issues patent for methodologies for abating a broad range of allergens, pathogens, viruses, bacteria

Maternal deaths following cesarean delivery can be reduced

Maternal deaths following cesarean delivery can be reduced

U.S. EPA calls out nation's largest manufacturer of hospital disinfectants

U.S. EPA calls out nation's largest manufacturer of hospital disinfectants

ShangRing - innovative circumcision device

ShangRing - innovative circumcision device

Immunotherapy shows promise in high-risk pediatric sarcomas

Immunotherapy shows promise in high-risk pediatric sarcomas

Fatal flaws in the way new drugs are tested and marketed

Fatal flaws in the way new drugs are tested and marketed

New studies examine use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C

New studies examine use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C

New oral vaccine combats various versions of the plague

New oral vaccine combats various versions of the plague

ISU researchers find possible alternative adjuvant for alum to boost the effectiveness of vaccines

ISU researchers find possible alternative adjuvant for alum to boost the effectiveness of vaccines

Australian Alzheimer's trial published in the Lancet

Australian Alzheimer's trial published in the Lancet

Alzheimer's disease patients show improvement in trial of new drug

Alzheimer's disease patients show improvement in trial of new drug

U.S. authorities seize Xiadafil VIP tablets after company refuses to recall product

U.S. authorities seize Xiadafil VIP tablets after company refuses to recall product

Bioscience fund GBS invests US$6m in Xenome

Bioscience fund GBS invests US$6m in Xenome

Gilead initiates phase III trial of Elvitegravir

Gilead initiates phase III trial of Elvitegravir

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.